Skip to main content
NCBI home page
British Heart Journal logoLink to British Heart Journal
. 1995 Sep;74(3):215–219. doi: 10.1136/hrt.74.3.215

Is aspirin safe for patients with heart failure?

J G Cleland 1, C J Bulpitt 1, R H Falk 1, I N Findlay 1, C M Oakley 1, G Murray 1, P A Poole-Wilson 1, C R Prentice 1, G C Sutton 1
PMCID: PMC484008  PMID: 7547012

Full text

PDF
215

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baker D. W., Wright R. F. Management of heart failure. IV. Anticoagulation for patients with heart failure due to left ventricular systolic dysfunction. JAMA. 1994 Nov 23;272(20):1614–1618. doi: 10.1001/jama.272.20.1614. [DOI] [PubMed] [Google Scholar]
  2. Baur L. H., Schipperheyn J. J., van der Laarse A., Souverijn J. H., Frölich M., de Groot A., Voogd P. J., Vroom T. F., Cats V. M., Keirse M. J. Combining salicylate and enalapril in patients with coronary artery disease and heart failure. Br Heart J. 1995 Mar;73(3):227–236. doi: 10.1136/hrt.73.3.227. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Birkebaek N. H., Vejby-Christensen H., Jakobsen P., Winther K. The effect of nifedipine and captopril on platelet activation and prostanoid production in essential hypertension. J Hypertens Suppl. 1988 Dec;6(4):S378–S380. doi: 10.1097/00004872-198812040-00118. [DOI] [PubMed] [Google Scholar]
  4. Boysen G., Sørensen P. S., Juhler M., Andersen A. R., Boas J., Olsen J. S., Joensen P. Danish very-low-dose aspirin after carotid endarterectomy trial. Stroke. 1988 Oct;19(10):1211–1215. doi: 10.1161/01.str.19.10.1211. [DOI] [PubMed] [Google Scholar]
  5. Cleland J. G. ACE inhibitors for myocardial infarction: how should they be used? Eur Heart J. 1995 Feb;16(2):153–159. doi: 10.1093/oxfordjournals.eurheartj.a060879. [DOI] [PubMed] [Google Scholar]
  6. Cleland J. G., Dargie H. J., Ford I. Mortality in heart failure: clinical variables of prognostic value. Br Heart J. 1987 Dec;58(6):572–582. doi: 10.1136/hrt.58.6.572. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Cleland J. G., Poole-Wilson P. A. ACE inhibitors for heart failure: a question of dose. Br Heart J. 1994 Sep;72(3 Suppl):S106–S110. doi: 10.1136/hrt.72.3_suppl.s106. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Cleland J. G. The clinical course of heart failure and its modification by ACE inhibitors: insights from recent clinical trials. Eur Heart J. 1994 Jan;15(1):125–130. doi: 10.1093/oxfordjournals.eurheartj.a060364. [DOI] [PubMed] [Google Scholar]
  9. Clive D. M., Stoff J. S. Renal syndromes associated with nonsteroidal antiinflammatory drugs. N Engl J Med. 1984 Mar 1;310(9):563–572. doi: 10.1056/NEJM198403013100905. [DOI] [PubMed] [Google Scholar]
  10. Dzau V. J., Packer M., Lilly L. S., Swartz S. L., Hollenberg N. K., Williams G. H. Prostaglandins in severe congestive heart failure. Relation to activation of the renin--angiotensin system and hyponatremia. N Engl J Med. 1984 Feb 9;310(6):347–352. doi: 10.1056/NEJM198402093100603. [DOI] [PubMed] [Google Scholar]
  11. Elwood P. C., Cochrane A. L., Burr M. L., Sweetnam P. M., Williams G., Welsby E., Hughes S. J., Renton R. A randomized controlled trial of acetyl salicylic acid in the secondary prevention of mortality from myocardial infarction. Br Med J. 1974 Mar 9;1(5905):436–440. doi: 10.1136/bmj.1.5905.436. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Elwood P. C., Sweetnam P. M. Aspirin and secondary mortality after myocardial infarction. Lancet. 1979 Dec 22;2(8156-8157):1313–1315. doi: 10.1016/s0140-6736(79)92808-3. [DOI] [PubMed] [Google Scholar]
  13. Faulkner G., Prichard P., Somerville K., Langman M. J. Aspirin and bleeding peptic ulcers in the elderly. BMJ. 1988 Nov 19;297(6659):1311–1313. doi: 10.1136/bmj.297.6659.1311. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Ferri C., De Angelis C., Del Porto M. A., Leonetti Luparini R., Giarrizzo C., Santucci A., Balsano F. Blood platelets and angiotensin II: angiotensin II release after platelet aggregation. J Hypertens Suppl. 1988 Nov;6(1):S69–S71. [PubMed] [Google Scholar]
  15. Forster C., Anton F., Reeh P. W., Weber E., Handwerker H. O. Measurement of the analgesic effects of aspirin with a new experimental algesimetric procedure. Pain. 1988 Feb;32(2):215–222. doi: 10.1016/0304-3959(88)90070-X. [DOI] [PubMed] [Google Scholar]
  16. Gottlieb S. S., Robinson S., Krichten C. M., Fisher M. L. Renal response to indomethacin in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol. 1992 Oct 1;70(9):890–893. doi: 10.1016/0002-9149(92)90733-f. [DOI] [PubMed] [Google Scholar]
  17. Habib F., Dutka D., Crossman D., Oakley C. M., Cleland J. G. Enhanced basal nitric oxide production in heart failure: another failed counter-regulatory vasodilator mechanism? Lancet. 1994 Aug 6;344(8919):371–373. doi: 10.1016/s0140-6736(94)91402-8. [DOI] [PubMed] [Google Scholar]
  18. Hall D., Zeitler H., Rudolph W. Counteraction of the vasodilator effects of enalapril by aspirin in severe heart failure. J Am Coll Cardiol. 1992 Dec;20(7):1549–1555. doi: 10.1016/0735-1097(92)90449-w. [DOI] [PubMed] [Google Scholar]
  19. Jafri S. M., Ozawa T., Mammen E., Levine T. B., Johnson C., Goldstein S. Platelet function, thrombin and fibrinolytic activity in patients with heart failure. Eur Heart J. 1993 Feb;14(2):205–212. doi: 10.1093/eurheartj/14.2.205. [DOI] [PubMed] [Google Scholar]
  20. Juul-Möller S., Edvardsson N., Jahnmatz B., Rosén A., Sørensen S., Omblus R. Double-blind trial of aspirin in primary prevention of myocardial infarction in patients with stable chronic angina pectoris. The Swedish Angina Pectoris Aspirin Trial (SAPAT) Group. Lancet. 1992 Dec 12;340(8833):1421–1425. doi: 10.1016/0140-6736(92)92619-q. [DOI] [PubMed] [Google Scholar]
  21. Kannel W. B., Abbott R. D. Incidence and prognosis of unrecognized myocardial infarction. An update on the Framingham study. N Engl J Med. 1984 Nov 1;311(18):1144–1147. doi: 10.1056/NEJM198411013111802. [DOI] [PubMed] [Google Scholar]
  22. Katz S. D., Marantz P. R., Biasucci L., Jondeau G., Lee K., Brennan C., LeJemtel T. H. Low incidence of stroke in ambulatory patients with heart failure: a prospective study. Am Heart J. 1993 Jul;126(1):141–146. doi: 10.1016/s0002-8703(07)80021-4. [DOI] [PubMed] [Google Scholar]
  23. Klimt C. R., Knatterud G. L., Stamler J., Meier P. Persantine-Aspirin Reinfarction Study. Part II. Secondary coronary prevention with persantine and aspirin. J Am Coll Cardiol. 1986 Feb;7(2):251–269. doi: 10.1016/s0735-1097(86)80489-2. [DOI] [PubMed] [Google Scholar]
  24. Lin L., Nasjletti A. Role of endothelium-derived prostanoid in angiotensin-induced vasoconstriction. Hypertension. 1991 Aug;18(2):158–164. doi: 10.1161/01.hyp.18.2.158. [DOI] [PubMed] [Google Scholar]
  25. Manning W. J., Li W., Boyle N. G., Edelman R. R. Fat-suppressed breath-hold magnetic resonance coronary angiography. Circulation. 1993 Jan;87(1):94–104. doi: 10.1161/01.cir.87.1.94. [DOI] [PubMed] [Google Scholar]
  26. Middlekauff H. R., Stevenson W. G., Stevenson L. W. Prognostic significance of atrial fibrillation in advanced heart failure. A study of 390 patients. Circulation. 1991 Jul;84(1):40–48. doi: 10.1161/01.cir.84.1.40. [DOI] [PubMed] [Google Scholar]
  27. Nishimura H., Kubo S., Ueyama M., Kubota J., Kawamura K. Peripheral hemodynamic effects of captopril in patients with congestive heart failure. Am Heart J. 1989 Jan;117(1):100–105. doi: 10.1016/0002-8703(89)90662-5. [DOI] [PubMed] [Google Scholar]
  28. Pfeffer M. A., Braunwald E., Moyé L. A., Basta L., Brown E. J., Jr, Cuddy T. E., Davis B. R., Geltman E. M., Goldman S., Flaker G. C. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. N Engl J Med. 1992 Sep 3;327(10):669–677. doi: 10.1056/NEJM199209033271001. [DOI] [PubMed] [Google Scholar]
  29. Riegger G. A., Kahles H. W., Elsner D., Kromer E. P., Kochsiek K. Effects of acetylsalicylic acid on renal function in patients with chronic heart failure. Am J Med. 1991 May;90(5):571–575. [PubMed] [Google Scholar]
  30. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Arch Intern Med. 1994 Jul 11;154(13):1449–1457. [PubMed] [Google Scholar]
  31. Sbarouni E., Bradshaw A., Andreotti F., Tuddenham E., Oakley C. M., Cleland J. G. Relationship between hemostatic abnormalities and neuroendocrine activity in heart failure. Am Heart J. 1994 Mar;127(3):607–612. doi: 10.1016/0002-8703(94)90670-x. [DOI] [PubMed] [Google Scholar]
  32. Schwartz D., Kornowski R., Lehrman H., Averbuch M., Pines A., Greenland M., Finkelstein A., Levo Y. Combined effect of captopril and aspirin in renal hemodynamics in elderly patients with congestive heart failure. Cardiology. 1992;81(6):334–339. doi: 10.1159/000175826. [DOI] [PubMed] [Google Scholar]
  33. Shebuski R. J., Aiken J. W. Angiotensin II stimulation of renal prostaglandin synthesis elevates circulating prostacyclin in the dog. J Cardiovasc Pharmacol. 1980 Sep-Oct;2(5):667–677. doi: 10.1097/00005344-198009000-00015. [DOI] [PubMed] [Google Scholar]
  34. Sze P. C., Reitman D., Pincus M. M., Sacks H. S., Chalmers T. C. Antiplatelet agents in the secondary prevention of stroke: meta-analysis of the randomized control trials. Stroke. 1988 Apr;19(4):436–442. doi: 10.1161/01.str.19.4.436. [DOI] [PubMed] [Google Scholar]
  35. Townend J. N., Doran J., Lote C. J., Davies M. K. Peripheral haemodynamic effects of inhibition of prostaglandin synthesis in congestive heart failure and interactions with captopril. Br Heart J. 1995 May;73(5):434–441. doi: 10.1136/hrt.73.5.434. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Weil J., Colin-Jones D., Langman M., Lawson D., Logan R., Murphy M., Rawlins M., Vessey M., Wainwright P. Prophylactic aspirin and risk of peptic ulcer bleeding. BMJ. 1995 Apr 1;310(6983):827–830. doi: 10.1136/bmj.310.6983.827. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Yusuf S., Pepine C. J., Garces C., Pouleur H., Salem D., Kostis J., Benedict C., Rousseau M., Bourassa M., Pitt B. Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions. Lancet. 1992 Nov 14;340(8829):1173–1178. doi: 10.1016/0140-6736(92)92889-n. [DOI] [PubMed] [Google Scholar]
  38. Zusman R. M. Effects of converting-enzyme inhibitors on the renin-angiotensin-aldosterone, bradykinin, and arachidonic acid-prostaglandin systems: correlation of chemical structure and biologic activity. Am J Kidney Dis. 1987 Jul;10(1 Suppl 1):13–23. [PubMed] [Google Scholar]
  39. van Wijngaarden J., Smit A. J., de Graeff P. A., van Gilst W. H., van der Broek S. A., van Veldhuisen D. J., Lie K. I., Wesseling H. Effects of acetylsalicylic acid on peripheral hemodynamics in patients with chronic heart failure treated with angiotensin-converting enzyme inhibitors. J Cardiovasc Pharmacol. 1994 Feb;23(2):240–245. [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES